Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000071.xml
Download PDF
Semin Neurol 2007; 27(1): 066-077
DOI: 10.1055/s-2006-956757
DOI: 10.1055/s-2006-956757
Vascular Dementia: Emerging Trends
Further Information
Publication History
Publication Date:
17 January 2007 (online)
ABSTRACT
Vascular dementia is a term used to describe a constellation of cognitive and functional impairment that can be viewed as a subset of the larger syndrome of vascular cognitive impairment associated with cerebrovascular brain injury. Vascular dementia is a common disorder among the elderly, although it can also occur in younger persons. Comprising 20% of all cases of dementia in the United States, vascular dementia is the second most common form of dementia after Alzheimer's disease. Patients with vascular dementia often exhibit mood and behavioral changes and may have focal neurological signs on neurological examination. Primary treatment is through primary or secondary modification of cerebrovascular risk factors such as hypertension, although symptomatic treatments with cholinesterase inhibitors have shown modest symptomatic benefit.
KEYWORDS
Vascular dementia - diagnostic criteria - pathophysiology - neuroimaging - treatment
REFERENCES
- 1 Roman G C, Tatemichi T K, Erkinjuntti T et al.. Vascular dementia: diagnostic criteria for research criteria for research studies (report of the NINCDS-AIREN International Work Group). Neurology. 1993; 43 250-260
- 2 Meyer J S, Muramatsu K, Mortel K F, Obara K, Shirai T. Prospective CT confirms differences between vascular and Alzheimer's dementia. Stroke. 1995; 26 735-742
- 3 Hachinski V C, Iliff L D, Zilhka E et al.. Cerebral blood flow in dementia. Arch Neurol. 1975; 32 632-637
- 4 Small G W. Revised ischemic score for diagnosing multi-infarct dementia. J Clin Psychiatry. 1985; 46 514-517
- 5 Rosen W G, Terry R D, Fuld P A et al.. A pathological verification of ischemic score in differentiation of dementias. Ann Neurol. 1980; 7 486-488
- 6 Chui H C, Victoroff J I, Margolin D et al.. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992; 42 473-480
- 7 Pohjasvaara T, Mantyla R, Salonen O et al.. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to post stroke dementia. Arch Neurol. 2000; 57 1295-1300
- 8 Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC; American Psychiatric Association, DSM-IV 1994
MissingFormLabel
- 9 International Statistical Classification of Disease and Related Health Problems. 1989
Rev. Geneva; World Health Organization 1992: 311-388
MissingFormLabel
- 10 Knopman D S, Parisi J E, Boeve B F et al.. Vascular dementia in a community-based autopsy study. Arch Neurol. 2003; 60 569-575
- 11 Gold G, Bouras C, Canuto A et al.. Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry. 2002; 159 82-87
- 12 Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry. 1999; 174 45-50
- 13 Merino J G, Hachinski V.
Diagnosis of vascular dementia: conceptual challenges . In: Paul RH, Cohen R, Ott BR, Salloway S Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management. Totowa, NJ; Humana Press 2005: 57-71MissingFormLabel - 14 Roman G C. Vascular dementia revisited: diagnosis, pathogenesis, treatment and prevention. Med Clin North Am. 2002; 86 477-499
- 15 Konno S, Meyer J S, Terayama Y, Margishvili G M, Mortel K F. Classification, diagnosis and treatment of vascular dementia. Drugs Aging. 1997; 11 361-373
- 16 Mahler M E, Cummings J L. Behavioral neurology of multi-infarct dementia. Alzheimer Dis Assoc Disord. 1991; 5 122-130
- 17 Cummings J L. Subcortical Dementia. 3rd ed. New York; Oxford University Press 1990
MissingFormLabel
- 18 Desmond D W, Moroney J T, Lynch T et al.. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke. 1999; 30 1230-1233
- 19 Fisher C M. Lacunes: small deep cerebral infarcts. Neurology. 1965; 15 774-784
- 20 Wolfe N, Linn R, Babikian V L et al.. Frontal systems impairment following multiple lacunar infarcts. Arch Neurol. 1990; 47 129-132
- 21 Babikian V, Ropper A. Binswanger's disease: a review. Stroke. 1987; 18 2-12
- 22 Pantoni L, Garcia J H. Pathogenesis of leukoaraiosis: a review. Stroke. 1997; 28 652-659
- 23 Caplan L R. Binswanger's disease-revisited. Neurology. 1995; 45 626-633
- 24 Nyenhuis D, Gorelick P B. Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment. J Am Geriatr Soc. 1998; 46 1437-1448
- 25 Hebert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology. 1995; 14 240-257
- 26 Hofman A, Rocca W A, Brayne C et al.. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol. 1991; 20 736-748
- 27 Skoog I, Nilsson L, Palmertz B, Andreasson L A, Svanborg A. A population based study of dementia in 85 year olds. N Engl J Med. 1993; 328 153-158
- 28 Rocca W A, Hofman A, Brayne C et al.. The prevalence of vascular dementia in Europe: facts and fragments from 1980-1990 studies. EURODEM-Prevalence Research Group. Ann Neurol. 1991; 30 817-824
- 29 Chui H C. Dementia: a review emphasizing clinicopathologic correlation and brain-behavior relationships. Arch Neurol. 1989; 46 806-814
- 30 Ueda K, Kawano H, Hasuo Y, Fujishima M. Prevalence and etiology of dementia in a Japanese community. Stroke. 1992; 23 798-803
- 31 Yoshitake T, Kiyohara Y, Kato I et al.. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study. Neurology. 1995; 45 1161-1168
- 32 Petrovitch H, White L, Masaki K H et al.. Influence of myocardial infarction, coronary artery bypass surgery, and stroke on cognitive impairment in late life. Am J Cardiol. 1998; 81 1017-1021
- 33 Tatemichi T K, Desmond D W, Mayeux R et al.. Dementia after stroke: baseline frequency, risks, and clinical features in hospitalized cohort. Neurology. 1992; 42 1185-1193
- 34 Hulette C, Nochlin D, McKeel D et al.. Clinical-neuropathologic findings in multi infarct dementia: a report of six autopsied cases. Neurology. 1997; 48 668-672
- 35 Rockwood K, Elby E, Hachinski V, Hogan D. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol. 1997; 54 33-39
- 36 Moroney J T, Bagiella E, Desmond D W, Paik M C, Stern Y, Tatemichi T K. Risk factors for incident dementia after stroke: role of hypoxic and ischemic disorders. Stroke. 1996; 27 1283-1289
- 37 Skoog I, Nilssen I, Palmertz B, Andreasson L A, Svanborg A. A population based study of dementia in 85 year olds. N Engl J Med. 1993; 328 153-158
- 38 Brun A, Englund E. A white matter disorder in dementia of the AD type: a pathoanatomical study. Ann Neurol. 1986; 19 253-262
- 39 Englund E, Brun A, Alling C. White matter changes in dementia of Alzheimer's type: biochemical and neuropathological correlates. Brain. 1988; 111 1425-1439
- 40 Desmond D W, Moroney J T, Sano M, Stern Y. Recovery of cognitive function after stroke. Stroke. 1996; 27 1798-1803
- 41 PROGRESS Collaborative Group . Randomized trial of a preindopril-based blood pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischemic attack. Lancet. 2001; 358 1033-1041
- 42 Tatemichi T K, Desmond D W, Mayeux R et al.. Dementia after a stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 1992; 42 1185-1193
- 43 Gorelick P B. Status of risk factors for dementia associated with stroke. Stroke. 1997; 28 459-463
- 44 Henon H, Durieu I, Guerouaou D et al.. Post stroke dementia: incidence and relationship to prestroke cognitive decline. Neurology. 2001; 57 1216-1222
- 45 Breteler M MB, Claus J J, Grobbee D E, Hofman A. Cardiovascular disease and distribution of cognitive functioning elderly people: the Rotterdam study. BMJ. 1994; 308 1604-1608
- 46 Lenzen H J, Assman G, Buchwalksy R, Schulte H. Association of apolipoprotein E polymorphism, low density lipoprotein cholesterol and coronary heart disease. Clin Chem. 1986; 32 778-781
- 47 Gerdes L U, Gerdes C, Kervinen K et al.. The apoplipoprotein epsilon 4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian simvastatin survival study. Circulation. 2000; 101 1366-1371
- 48 Wilson P WF, Myers R H, Larson M G, Ordovas J M, Wolf P A, Schaefer E J. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. JAMA. 1994; 272 1666-1671
- 49 Saunders A M, Roses A D. Apolipoprotein E allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. [letter]. Stroke. 1993; 24 1416-1417
- 50 Frisoni G B, Geroldi C, Bianchetti A et al.. Apolipoprotein allele frequency in vascular dementia and Alzheimer's disease. [letter]. Stroke. 1994; 25 1703-1704
- 51 Greenberg S M, Rebeck G W, Vonsattel J PV et al.. Apolipoprotein E e4 and cerebral hemorrhage associated with amyloid angiopathy. Neurology. 1993; 43 2073-2079
- 52 Kalaria R N, Premkumar D RD. Apolipoprotein E genotypes and cerebral amyloid angiopathy. Lancet. 1995; 346 1424-1425
- 53 Premkumar D RD, Hedera P, Friedland R P, Kalaria R N. Apolipoprotein E e4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology in Alzheimer's disease. Am J Pathol. 1996; 148 2083-2095
- 54 Frackowiak R S, Pozzilli C, Legg N J et al.. Regional cerebral oxygen supply and utilization in dementia: a clinical and physiological study with oxygen-15 and positron tomography. Brain. 1981; 104 753-778
- 55 Skoog I, Lernfelt B, Landahl S et al.. 15 year longitudinal study of blood pressure and dementia. Lancet. 1996; 347 1141-1145
- 56 Elias M F, Sullivan L M, D'Agostino R B et al.. Framingham stroke risk profile and lowered cognitive performance. Stroke. 2004; 35 404-409
- 57 Elias M F, Wolf P A, D'Agostino R B, Cobb J, White L R. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol. 1993; 138 353-364
- 58 Hebert L E, Scherr P A, Bennett D A et al.. Blood pressure and late-life cognitive function change: a biracial longitudinal population study. Neurology. 2004; 62 2021-2024
- 59 Rockwood K, Ebly E, Hachinski V, Hogan D. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol. 1997; 54 33-39
- 60 Gorelick P B, Roman G C. Vascular dementia: a time to “seize the moment.” Neuroepidemiology. 1993; 12 139-140
- 61 Swan G E, DeCarli C, Miller B L, Reed T, Carmelli D. Biobehavioral characteristics of non demented older adults with subclinical brain atrophy. Neurology. 2000; 54 2108-2114
- 62 Vermeer S E, Den Heijer T, Koudstaal P J et al.. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2003; 34 392-396
- 63 Longstreth Jr W T, Arnold A M, Manolio T A et al.. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Collaborative Research Group. Neuroepidemiology. 2000; 19 30-34
- 64 de Groot J C, de Leeuw F E, Breteler M M. Cognitive correlates of cerebral white matter changes. J Neural Transm Suppl. 1998; 53 41-67
- 65 de Groot J C, de Leeuw F E, Oudkerk M et al.. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol. 2000; 47 145-151
- 66 DeCarli C. The role of cerebrovascular disease in dementia. Neurologist. 2003; 9 123-136
- 67 Longstreth Jr W T, Bernick C, Manolio T A et al.. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol. 1998; 55 1217-1225
- 68 DeCarli C, Massaro J, Harvey D et al.. Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal. Neurobiol Aging. 2005; 26 491-510
- 69 Bernick C, Kuller L, Dulbert C et al.. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology. 2001; 57 1222-1229
- 70 Wentzel C, Rockwood K, MacKnight C et al.. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology. 2001; 57 714-716
- 71 Hachinski V C, Potter P, Merskey H. Leuko-araiosis. Arch Neurol. 1987; 44 21-23
- 72 Pantoni L, Garcia J. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. Stroke. 1995; 26 1293-1301
- 73 Schmidt R, Fazekas F, Kocch M et al.. Magnetic resonance imaging cerebral abnormalities and neuropsychologic test performance in elderly hypertensive subjects. Arch Neurol. 1995; 52 905-910
- 74 Longstreth Jr W T, Arnold A M, Manolio T A et al.. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Collaborative Research Group. Neuroepidemiology. 2000; 19 30-34
- 75 DeCarli C, Miller B L, Swan G E, Reed T, Wolf P A, Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung and Blood Institute Twin Study. Arch Neurol. 2001; 58 643-647
- 76 De Groot J C, de Lieu F E, Oudkerk M et al.. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol. 2000; 47 145-151
- 77 Wu C C, Mungas D, Petkov C I et al.. Brain structure cognition in a community sample of elderly Latinos. Neurology. 2002; 59 383-391
- 78 Kuller L H, Shemanski L, Manolio T et al.. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke. 1998; 29 388-398
- 79 Au R, Massaro J M, DeCarli C et al.. Association of white matter hyperintensity volume is associated with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol. 2006; 63 246-250
- 80 Tomlinson B E, Blessed G, Roth M. Observations on the brains of non-demented old people. J Neurol Sci. 1968; 7 331-356
- 81 Olsson Y, Brun A, Englund E. Fundamental pathological lesions in vascular dementia. Acta Neurol Scand Suppl. 1996; 168 31-38
- 82 White L, Petrovitch H, Hardman J et al.. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann NY Acad Sci. 2002; 977 9-23
- 83 Schneider J A, Wilson R S, Cochran E J et al.. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology. 2003; 60 1082-1088
- 84 Schneider J A, Wilson R S, Bienias J L, Evans D A, Bennett D A. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004; 62 1148-1155
- 85 Heyman A, Fillenbaum G G, Welsh-Bohmer K A et al.. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's disease. Neurology. 1998; 51 159-162
- 86 Snowdon D A, Greiner L H, Mortimer J A et al.. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA. 1997; 277 813-817
- 87 Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol. 1987; 234 371-376
- 88 Ellis R J, Olichney J M, Thal L J et al.. Cerebral amyloid angiopathy in the brain of patients with Alzheimer's disease: the CERAD experience part XV. Neurology. 1996; 46 1592-1596
- 89 Leys D, Pruvo J P, Parent M et al.. Could Wallerian degeneration contribute to “Leuko-araiosis” in subjects free of any vascular disorder?. J Neurol Neurosurg Psychiatry. 1991; 54 46-50
- 90 Hofman A, Ott A, Breteler M M et al.. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997; 349 151-154
- 91 Kalaria R N. Arteriosclerosis, apolipoprotein E, and Alzheimer's disease. Lancet. 1997; 349 1174
- 92 Tatemichi T K. How acute brain failure becomes chronic: a view of the mechanisms of dementia related to stroke. Neurology. 1990; 40 1652-1659
- 93 Erkinjuntti T. Vascular dementia: challenge of clinical diagnosis. Int Psychogeriatr. 1997; 9(suppl 1) 51-58
- 94 Teng E L, Chui H C. The modified mini-mental state (3MS) examination. J Clin Psychiatry. 1987; 48 314-318
- 95 Royall D R, Cordes J A, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry. 1998; 64 588-594
- 96 Royall D R, Mulroy A R, Chiodo L K, Polk M J. Clock drawing is sensitive to executive control: a comparison of six methods. J Gerontol B Psychol Sci Soc Sci. 1999; 54 P328-P333
- 97 Fein G, Di Sclafani V, Tanabe J et al.. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology. 2000; 55 1626-1635
- 98 Salmon E, Sadzot B, Maquet P et al.. Differential diagnosis of Alzheimer's disease with PET. J Nucl Med. 1994; 35 391-398
- 99 Nagata K, Maruya H, Yuya H et al.. Can PET data differentiate AD from VaD?. Ann NY Acad Sci. 2000; 903 252-261
- 100 Starkstein S E, Sabe L, Vazquez S et al.. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke. 1996; 27 408-414
- 101 Tatemichi T K, Paik M, Bagiella E et al.. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology. 1994; 44 1885-1891
- 102 Choi S H, Na D L, Chung C S et al.. Diffusion-weighted MRI in vascular dementia. Neurology. 2000; 54 83-89
- 103 Fellgiebel A, Willee P, Muller M J et al.. Ultrastructural hippocampal and white matter alterations in mid cognitive impairment: a diffusion tensor imaging study. Dement Geriatr Cogn Disord. 2004; 18 101-108
- 104 Kantarci K, Petersen R C, Boeve B F et al.. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology. 2005; 64 902-904
- 105 Kantarci K, Xu Y, Shiung M M et al.. Comparative diagnostic utility of different MRI modalities in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord. 2002; 14 198-207
- 106 Gorelick P B, Erkinjuntti T, Hofman A et al.. Prevention of vascular dementia. Alzheimer Dis Assoc Disord. 1999; 13(suppl 3) S131-S139
- 107 Launer L J, Mansaki K. The association between midlife blood pressure levels, and late-life cognitive function. JAMA. 1995; 274 1846-1851
- 108 Forette F, Seux M L, Staessen J A et al.. Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet. 1998; 352 1347-1351
- 109 Knopman D, Bloand L L, Mosley T et al.. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001; 56 42-48
- 110 Gueyffier F, Boissel J P, Boutitie F et al.. Effect of antihypertensive treatment in patients having already suffered from stroke: gathering the evidence. The INDANA (Individual Data Analysis of Antihypertensive intervention trials) Project Collaborators. Stroke. 1997; 28 2557-2562
- 111 Tzourio C, Anderson C, Chapman N et al.. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. PROGRESS Collaborative Group. Arch Intern Med. 2003; 163 1069-1075
- 112 Streja D A.
The subacute stroke patient: lipid management . In: Cohen SN Management of Ischemic Stroke. New York; McGraw Hill 2000: 119-131MissingFormLabel - 113 Gorelick P B, Mazzone T. Plasma lipids and stroke. J Cardiovasc Risk. 1999; 6 217-221
- 114 Galanis D J, Petrovitch H, Launer L J, Harris T B, Foley D J, White L R. Smoking history in middle age and subsequent cognitive performance in elderly Japanese-American men: the Honolulu-Asia Aging Study. Am J Epidemiol. 1997; 145 507-515
- 115 Rockwood K, Kirkland S, Hogan D B et al.. Use of lipid lowering agents indications bias, and the risk of dementia in community dwelling elderly people. Arch Neurol. 2002; 59 223-227
- 116 Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000; 342 145-153
- 117 Roman G C. Facts, myths and controversies in vascular dementia. J Neurol Sci. 2004; 226 49-52
- 118 Mesulam M, Siddique T, Cohen B. Cholinergic denervation in a pure multifactor state: observations on CADASIL. Neurology. 2003; 60 1183-1185
- 119 Erkinjuntti T, Inzitari D, Pantoni L et al.. Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Ann NY Acad Sci. 2000; 903 262-272
- 120 Erkinjuntti T, Kurz A, Gauthier S et al.. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. Lancet. 2002; 359 1283-1290
- 121 Mendez M F, Younesi F L, Perryman K M. Use of donepezil for vascular dementia: preliminary clinical experience. J Neuropsychiatry Clin Neurosci. 1999; 11 268-270
- 122 Pratt R D, Perdorno C A. Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits. Ann NY Acad Sci. 2002; 977 513-522
- 123 Moretti R, Torre P, Antonello R M, Cazzato G, Bava A. Rivastigmine in subcortical vascular dementia: an open 22-month study. J Neurol Sci. 2002; 203-204 141-146
Neelum T AggarwalM.D.
Rush Alzheimer's Disease Center
600 S. Paulina, Suite 1027D, Chicago, IL 60612